Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;4(2):89-94.
doi: 10.1177/1756283X10392444.

Correlation between serum gastrin and cellular proliferation in Barrett's esophagus

Daniel A Green  1 , Carrie M Mlynarczyk, Benjamin J Vaccaro, Kristina M Capiak, Michael Quante, Charles J Lightdale, Julian A Abrams
Affiliations
Free PMC article

Correlation between serum gastrin and cellular proliferation in Barrett's esophagus

Daniel A Green et al. Ther Adv Gastroenterol. 2011 Mar.
Free PMC article

Abstract

Background: Patients with Barrett's esophagus (BE) are commonly treated with proton-pump inhibitors (PPIs) to minimize the exposure of esophageal mucosa to stomach acid. However, the use of these medications can lead to significant hypergastrinemia in a subset of patients, which is concerning due to the known tumorigenic and proliferative effects of gastrin. The present pilot study aims to investigate a potential correlation between serum gastrin and cellular proliferation in BE.

Methods: We performed a cross-sectional analysis of patients with nondysplastic BE on PPI therapy. Fasting serum gastrin was measured on the same day as esophageal biopsies were obtained. These biopsies were then stained with Ki-67 nuclear antibody. Pearson's correlation coefficient was calculated to assess the relationship between Ki-67 index and ln(gastrin).

Results: A total of 10 patients were included in the study. The mean age was 62.6 (±8.4) years and 5 patients were male. The median serum gastrin level was 45.2 pM (interquartile range [IQR] 33-113) and the median Ki-67 index was 49.6% (IQR 23-64). We found a statistically significant positive correlation between Ki-67 index and ln(gastrin) (r = 0.64; p = 0.05).

Conclusions: In nondysplastic BE patients on PPI therapy, serum gastrin levels were significantly correlated with cellular proliferation. These pilot data lend support to a potential causal effect of gastrin on neoplastic progression in BE. Longitudinal studies of patients with BE are needed to determine whether hypergastrinemia is a risk factor for the development of dysplasia and adenocarcinoma or could be used as a biomarker for disease progression.

Keywords: Barrett’s esophagus; cellular proliferation; esophageal cancer; gastrin.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Photomicrograph of a representative Barrett’s gland stained with Ki-67 nuclear antibody.
Figure 2.
Figure 2.
Significant correlation between Ki-67 index and ln(gastrin) in patients with nondysplastic Barrett’s esophagus.
See this image and copyright information in PMC

References

    1. Binato M., Gurski R.R., Fagundes R.B., Meurer L., Edelweiss M.I. (2009) P53 and Ki-67 overexpression in gastroesophageal reflux disease—Barrett’s esophagus and adenocarcinoma sequence. Dis Esophagus 22: 588–595. - PubMed
    1. Conio M., Filiberti R., Blanchi S., Ferraris R., Marchi S., Ravelli P., et al. (2002) Risk factors for Barrett’s esophagus: a case-control study. Int J Cancer 97: 225–229. - PubMed
    1. Feith M., Stein H.J., Mueller J., Siewert J.R. (2004) Malignant degeneration of Barrett’s esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53. Dis Esophagus 17: 322–327. - PubMed
    1. Ferrand A., Wang T.C. (2006) Gastrin and cancer: a review. Cancer Lett 238: 15–29. - PubMed
    1. Fox J.G., Wang T.C., Rogers A.B., Poutahidis T., Ge Z., Taylor N., et al. (2003) Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 124: 1879–1890. - PubMed

LinkOut - more resources